News

• September 19, 2012
  

  Drug Makers Join Efforts in Research

  Ten of the world’s largest pharmaceutical companies said on Wednesday that they would cooperate on research aimed at accelerating drug development, starting with streamlining clinical trials.
• September 13, 2012
  

  Consortium Brings Together FDA, Industry to Release New Data Reporting Standard

  Officials with the Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path), two organizations strongly affiliated with the US Food and Drug Administration (FDA), have announced the release of a new “breakthrough tool” used to help combine and report data from multiple studies.
• September 13, 2012
  

  FDA, IMI, and Patient Advocates to Present at CDISC 2012 International Interchange Formal Launch of CFAST – Collaboration between C-Path and CDISC

  The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the launch of the Coalition For Accelerating Standards and Therapies (CFAST), a follow-up to the partnership agreement signed earlier this year. The official launch of CFAST will take place at the CDISC 2012 International Interchange in Baltimore, Maryland (24-26 October 2012).
• September 7, 2012
  

  C-Path, CDISC launch “breakthrough” tool for TB drug development

  A “breakthrough” tool that standardises reporting of research data in the development of drug regimens to combat tuberculosis (TB) has been launched by the US-based Critical Path Institute (C-Path) and Clinical Data Interchange Standards Consortium (CDISC).
• August 18, 2012
  

  Science foundation invaluable to Arizona

  The inclusion of C-Path in the Star’s centennial “100 Days of Science” series is a most welcome honor. What needs to be highlighted is the pivotal role that Science Foundation Arizona (SFAz) has played in C-Path’s success. SFAz provided over $14 million, a sum guaranteeing C-Path’s independence and allowing C-Path to become the trusted, neutral...